Article Information
History
- May 3, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eduard Grebe, PhD1,*#,
- Alex Welte, PhD1#,
- Jake Hall, BSc2,
- Sheila M. Keating, PhD, MSPH3,4,
- Shelley N. Facente, MPH4,
- Kara Marson, MPH4,
- Jeffrey N. Martin, PhD5,
- Susan J. Little, MD5,
- Matthew A. Price, PhD4,6,
- Esper G. Kallas, MD, PhD7,
- Michael P. Busch, MD, PhD3,4,
- Christopher D. Pilcher, MD, PhD4,
- Gary Murphy, PhD2,
- on behalf of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
- 1South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa;
- 2Public Health England, London, United Kingdom;
- 3Blood Systems Research Institute, San Francisco, CA;
- 4University of California, San Francisco, San Francisco, CA;
- 5University of California, San Diego, San Diego, CA;
- 6Department of Medical Affairs, International AIDS Vaccine Initiative (IAVI), New York City, NY;
- 7Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, Brazil.
- ↵*Corresponding author:
Eduard Grebe, SACEMA, 19 Jonkershoek Avenue, Stellenbosch 7600, South Africa. Tel: +27 21 8082778. Email: eduardgrebe{at}sun.ac.za.
↵# These authors contributed equally.
Author Contributions: E.G. and A.W. analysed the data and wrote the manuscript; G.M., J.H. and S.M.K. conducted the laboratory testing; S.N.F., K.M. and E.G. managed specimen repository and clinical data; G.M., A.W., C.D.P., and M.P.B. were principal investigators for the study and provided input on analysis; J.N.M., S.L., M.A.P., E.G.K., and C.D.P. were principal investigators for the clinical cohorts; G.M. conceived and oversaw the study; All authors reviewed and provided input on the manuscript.